Free Trial
$100 Off. Every Year. Lock In MarketBeat All Access at $149
Claim the Rate Lock
Claim MarketBeat All Access Sale Promotion

Danaher Corporation $DHR Stock: Private Wealth Partners LLC Decreases Stake

Danaher logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Private Wealth Partners LLC reduced its Danaher stake by 5% in the third quarter, selling 4,416 shares and retaining 83,559 shares valued at approximately $18.5 million. Institutional investors collectively own 79.05% of Danaher.
  • Danaher reported third-quarter adjusted earnings of $2.11 per share, beating estimates of $1.92, while revenue rose 8.3% year over year to about $6.55 billion. Management also raised its full-year 2026 adjusted EPS outlook.
  • Analysts remain broadly bullish, with a consensus “Moderate Buy” rating and a $242.91 price target, although tariff pressure, execution concerns and a cautious 2027 outlook have limited the stock’s immediate reaction. Shares recently traded at $230.36, and Danaher announced a quarterly dividend of $0.40 per share.
  • Is Danaher on your watchlist? MarketBeat All Access adds unlimited watchlist stocks and real-time alerts for $149 a year, a rate that never goes up while you are a member.

Private Wealth Partners LLC lessened its position in Danaher Corporation (NYSE:DHR - Free Report) by 5.0% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 83,559 shares of the conglomerate's stock after selling 4,416 shares during the quarter. Danaher makes up about 1.3% of Private Wealth Partners LLC's portfolio, making the stock its 22nd biggest position. Private Wealth Partners LLC's holdings in Danaher were worth $18,513,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of the company. Marquette Asset Management LLC boosted its position in Danaher by 192.1% during the 3rd quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate's stock worth $25,000 after acquiring an additional 73 shares during the last quarter. N.E.W. Advisory Services LLC acquired a new stake in shares of Danaher in the second quarter valued at approximately $25,000. Main Street Group LTD bought a new stake in shares of Danaher in the first quarter worth $25,000. Field & Main Bank bought a new stake in shares of Danaher in the second quarter worth $29,000. Finally, Evolution Wealth Management Inc. boosted its holdings in Danaher by 208.0% during the first quarter. Evolution Wealth Management Inc. now owns 154 shares of the conglomerate's stock worth $29,000 after purchasing an additional 104 shares during the last quarter. Institutional investors own 79.05% of the company's stock.

Analyst Ratings Changes

A number of research firms recently weighed in on DHR. The Goldman Sachs Group reaffirmed a "buy" rating and issued a $275.00 target price on shares of Danaher in a research report on Thursday. Guggenheim boosted their price target on shares of Danaher from $200.00 to $250.00 and gave the stock a "buy" rating in a research report on Thursday, October 1st. Barclays increased their price objective on shares of Danaher from $255.00 to $260.00 and gave the stock an "overweight" rating in a research note on Thursday. Evercore restated an "outperform" rating and issued a $230.00 price objective on shares of Danaher in a report on Monday, July 6th. Finally, Wells Fargo & Company lowered their target price on Danaher from $212.00 to $195.00 and set an "equal weight" rating on the stock in a research report on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and four have given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $242.91.

View Our Latest Analysis on DHR

Key Headlines Impacting Danaher

Here are the key news stories impacting Danaher this week:

  • Positive Sentiment: Danaher reported third-quarter adjusted earnings of $2.11 per share, above the $1.92 analyst consensus, while revenue reached approximately $6.55 billion. Revenue increased 8.3% year over year, and management raised its full-year 2026 adjusted EPS outlook. Danaher 3Q Net Up Sharply as Company Boosts 2026 Adjusted EPS View
  • Positive Sentiment: Analysts raised their valuation targets following the results. TD Cowen and JPMorgan lifted targets to $270, Goldman Sachs raised its target to $275, Stifel increased its target to $260, and Robert W. Baird raised its target to $254. The firms maintained bullish ratings, including Buy, Overweight and Outperform. Danaher Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Earnings
  • Positive Sentiment: Management highlighted margin strength, improved execution and an increased focus on innovation and artificial intelligence, factors analysts viewed as supporting a better longer-term outlook. Danaher Earnings Call Highlights Margin Strength, AI Push
  • Neutral Sentiment: Despite the earnings beat and higher targets, shares declined in the immediate post-results reaction, suggesting investors may have already priced in much of the improvement. A recent valuation comparison also frames DHR as a stock for investors weighing quality and growth against its relatively elevated valuation. Danaher Q3 Recap: Decent Results, Still A Hold
  • Negative Sentiment: Danaher’s new CEO emphasized the need for better execution and innovation. TD Cowen cited tariff pressure and a cautious 2027 outlook, creating uncertainty beyond the raised 2026 guidance and helping explain why the stock did not fully respond to the strong quarterly report. Danaher Posts First Earnings Under New CEO

Danaher Stock Up 0.3%

Shares of NYSE DHR traded up $0.61 during trading hours on Friday, hitting $230.36. The company had a trading volume of 3,935,897 shares, compared to its average volume of 4,912,513. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a quick ratio of 1.25, a current ratio of 1.63 and a debt-to-equity ratio of 0.45. The firm's 50 day moving average is $216.32 and its 200-day moving average is $197.35. The stock has a market capitalization of $161.94 billion, a P/E ratio of 37.70, a price-to-earnings-growth ratio of 2.87 and a beta of 0.76.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share for the quarter, topping analysts' consensus estimates of $1.92 by $0.19. Danaher had a net margin of 16.91% and a return on equity of 11.17%. The business had revenue of $6.55 billion for the quarter, compared to the consensus estimate of $6.56 billion. During the same period in the previous year, the company earned $1.89 earnings per share. The firm's revenue for the quarter was up 8.3% on a year-over-year basis. On average, analysts expect that Danaher Corporation will post 8.59 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 30th. Danaher's dividend payout ratio is presently 26.19%.

Danaher Profile

(Free Report)

Danaher Corporation NYSE: DHR is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.

See Also

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines